Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
halothane | Inhalation | N/A | |
isoflurane | Inhalation | N/A | |
ketamine | Injection | 50 mg (as hydrochloride)/mL in 10-mL vial | |
nitrous oxide | Inhalation | N/A | |
oxygen | Inhalation (medicine gas) | N/A | |
propofol | Injection | 1% | |
sevoflurane | Inhalation | N/A | |
thiopental | Injection | 1 g (as sodium) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bupivacaine | Injection | 0.5% (hydrochloride) with preservant | |
bupivacaine | Injection | 0.5% (hydrochloride) without preservant | |
bupivacaine | Injection for spinal anaesthesia | 0.5% (hydrochloride) in 20-ml ampoule to be mixed with 7.5% glucose solution | |
lidocaine | Dental cartridge | 2% (hydrochloride) | |
lidocaine | Injection | 2% (hydrochloride) + epinephrine 1:200 000 in vial + preservant | |
lidocaine | Injection | 2% (hydrochloride) in vial | |
lidocaine | Injection | 2% (hydrochloride) with preservant | |
lidocaine | Topical forms | 2% to 4% (hydrochloride) | |
lidocaine + epinephrine (adrenaline) | Dental cartridge | 2% (hydrochloride) + epinephrine 1:80 000 | |
lidocaine + epinephrine (adrenaline) | Injection | 2% (hydrochloride or sulfate) + epinephrine 1:200 000 in vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Injection | 1 mg (sulfate) in 1-ml ampoule | |
diazepam | Injection | 5 mg/mL | |
diazepam | Tablet (scored) | 10 mg | |
ethylephrine | Injection | 10mg/ml | |
fentanyl | Injection | 50 mcg (citrate)/mL | |
midazolam | Injection | 1 mg/ml | |
midazolam | Injection | 5 mg/mL | |
morphine | Injection | 10 mg (hydrochloride)/mL | |
promethazine | Injection | 25mg (hydrochloride)/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 500 mg | |
diclofenac | Injection | 25 mg (sodium)/mL | |
dipyrone (metamizole sodium) | Injection | 500 mg/ml | |
ibuprofen | Suspension | 100 mg/5 mL | |
ibuprofen | Tablet | 200 mg | |
ibuprofen | Tablet | 400 mg | |
naproxen | Tablet | 250 mg (sodium) | |
naproxen | Tablet | 500 mg (sodium) | |
paracetamol | Oral liquid | 120 mg/5 mL | |
paracetamol | Oral solution (drops) | 100mg/ml | |
paracetamol | Suppository | 100-300mg | |
paracetamol | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
codeine | Injection | 30mg (phosphate)/ml | |
codeine | Oral liquid | 10-15mg (phosphate)/5ml | |
codeine | Tablet | 30 mg (phosphate) | |
codeine | Tablet | 60mg (phosphate) | |
morphine | Injection | 10 mg (hydrochloride)/mL | |
morphine | Injection | 20 mg (hydrochloride)/mL | |
morphine | Oral liquid | 10 mg (sulfate)/5 mL | |
morphine | Tablet | 10 mg - 200 mg (morphine sulfate) | |
morphine | Tablet | 30 mg (sulfate) | |
morphine | Tablet (prolonged release) | 30 mg (morphine sulfate) | |
oxycodone | Tablet | 5mg (hydrochloride) | |
tramadol | Injection | 50 mg (hydrochloride)/mL | |
tramadol | Oral liquid | 100 mg (hydrochloride)/mL (as drops) | |
tramadol | Tablet | 50 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
allopurinol | Tablet | 100 mg | |
allopurinol | Tablet | 300 mg | |
colchicine | Tablet | 0.5mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aurothiomalate | Injection | 50mg (sodium)/ml | |
hydroxychloroquine | Tablet | 400mg (sulfate) or 310mg (pure) | |
penicillamine | Solid oral dosage form | 250 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorphenamine | Injection | 10mg (maleate)/ml | |
chlorphenamine | Oral liquid | 1mg (maleate)/ml | |
chlorphenamine | Oral liquid | 2 mg/5 ml (hydrogen maleate) | |
chlorphenamine | Tablet | 4 mg (hydrogen maleate) | |
dexamethasone | Injection | 4 mg/mL in 1-mL ampoule (as disodium phosphate salt) | |
epinephrine (adrenaline) | Injection | 1 mg (as hydrochloride or hydrogen tartrate) in 1-ml ampoule | |
hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
loratadine | Oral liquid | 5 mg/mL | |
loratadine | Tablet | 10 mg | |
methylprednisolone | Injection | 500 mg (sodium succinate) | |
prednisone | Tablet | 20 mg | |
prednisone | Tablet | 5 mg | |
prednisone | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
charcoal, activated | Powder | N/A | |
ipecacuanha | Oral liquid | 0.14% (7mg/5ml) total alkaloids |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylcysteine | Injection | 200 mg/ml in 10-ml ampoule | |
amyl nitrite | Inhalation | N/A | |
atropine | Injection | 0.5 mg/mL | |
atropine | Injection | 1 mg (sulfate) in 1-ml ampoule | |
calcium gluconate | Injection | 10% | |
cyanocobalamin | Injection | 1 mg/ml | |
dantrolene | Injection | 20 mg (sodium) | |
deferoxamine | Powder for injection | 500 mg (mesilate) in vial | |
dimercaprol | Injection in oil | 50 mg/mL in 2-mL ampoule | |
flumazenil | Injection | 100mcg/ml | |
methionine | Tablet | 250mg | |
methylthioninium chloride (methylene blue) | Injection | 10 mg/ml | |
naloxone | Injection | 400 mcg (hydrochloride) in 1-mL ampoule | |
penicillamine | Solid oral dosage form | 250 mg | |
potassium ferric hexacyano-ferrate(II) - 2H20 (Prussian blue) | Tablet | 500mg | |
pralidoxime | Injection | 1g (chlorohydrate) | |
sodium calcium edetate | Injection | 200 mg/ml in 5-ml ampoule | |
sodium nitrite | Injection | 30 mg/mL in 10-mL ampoule | |
sodium thiosulfate | Injection | 250 mg/mL in 50-mL ampoule | |
succimer | Solid oral dosage form | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbamazepine | Oral liquid | 100 mg/5 ml | |
carbamazepine | Tablet (scored) | 200 mg | |
clonazepam | Tablet | 2mg | |
clonazepam | Tablet | 500mcg | |
diazepam | Injection | 5 mg/mL | |
ethosuximide | Oral liquid | 250 mg/5 ml | |
ethosuximide | Tablet | 250 mg | |
gabapentin | Solid oral dosage form | 300 mg | |
lamotrigine | Tablet | 50 mg | |
magnesium sulfate | Injection | 200 mg/mL in 10-mL ampoule | |
magnesium sulfate | Injection | 500 mg/mL in 10-mL ampoule | |
phenobarbital | Injection | 100 mg (sodium)/mL in 2-mL ampoule | |
phenobarbital | Tablet | 100 mg | |
phenytoin | Injection | 50 mg/mL in 2-mL vial (sodium salt) | |
phenytoin | Injection | 50 mg/mL in 5-mL vial (sodium salt) | |
phenytoin | Oral liquid | 125 mg/5 mL | |
phenytoin | Solid oral dosage form | 100 mg (sodium salt) | |
valproic acid (sodium valproate) | Oral liquid | 200 mg/5 ml | |
valproic acid (sodium valproate) | Solution | 250 mg/5 mL | |
valproic acid (sodium valproate) | Tablet (enteric-coated) | 500 mg (sodium valproate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
albendazole | Oral liquid | 100mg/5ml | |
albendazole | Tablet | 200mg | |
albendazole | Tablet (chewable) | 400 mg | |
ivermectin | Oral liquid | 6mg/ml (drops) | |
ivermectin | Tablet (scored) | 6 mg | |
praziquantel | Tablet | 150 mg | |
praziquantel | Tablet | 600 mg | |
triclabendazole | Tablet | 250 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amipicillin + sulbactam | Injection | 1g (sodium) + 500mg (sodium) | |
amoxicillin | Oral liquid | 250 mg/5 mL | |
amoxicillin | Suspension | 500 mg/5 mL | |
amoxicillin | Tablet | 500 mg | |
amoxicillin + clavulanic acid | Oral liquid | 250 mg amoxicillin + 62.5 mg clavulanic acid/5 ml | |
amoxicillin + clavulanic acid | Tablet | 500 mg (as trihydrate) + 125 mg (as potassium salt) | |
ampicillin | Powder for injection | 1 g (as sodium salt) in vial | |
ampicillin | Powder for injection | 500 mg (as sodium salt) in vial | |
benzathine benzylpenicillin | Injection | 1 200 000 IU | |
benzathine benzylpenicillin | Injection | 2 400 000 IU | |
dicloxacillin | Oral liquid | 250mg/5ml | |
dicloxacillin | Tablet | 250mg | |
dicloxacillin | Tablet | 500mg | |
oxacillin | Injection | 1g | |
oxacillin | Injection | 500mg | |
phenoxymethylpenicillin | Oral liquid | 300,000 IU (as potassium)/5ml | |
phenoxymethylpenicillin | Tablet | 1,000,000 IU (as potassium) | |
potassium benzylpenicillin | Powder for injection | 5,000,000 IU | |
procaine benzylpenicillin | Powder for injection | 1 g (=1 million IU) in vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cefalexin | Oral liquid | 250 mg/5 mL | |
cefalexin | Tablet | 500 mg | |
cefazolin | Powder for injection | 1 g (as sodium salt) in vial | |
cefazolin | Powder for injection | 250 mg (as sodium salt) | |
cefotaxime | Injection | 500 mg (as sodium salt) | |
ceftazidime | Injection | 1 g | |
ceftriaxone | Powder for injection | 1 g (as sodium salt) in vial | |
ceftriaxone | Powder for injection | 250 mg (as sodium salt) in vial | |
cefuroxime | Suspension | 250 mg (axetil)/5 mL | |
cefuroxime | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
imipenem + cilastatin | Injection | 500mg + 500mg (as sodium) | |
meropenem | Injection | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
azithromycin | Oral liquid | 200 mg/5 mL | |
azithromycin | Tablet | 500 mg | |
clarithromycin | Solid oral dosage form | 500 mg | |
clarithromycin | Suspension | 250 mg/5 ml | |
clindamycin | Injection | 150 mg (as phosphate)/mL | |
clindamycin | Oral liquid | 75 mg/5 mL (as palmitate) | |
clindamycin | Tablet | 300 mg (as chlorohydrate) | |
erythromycin | Oral liquid | (as stearate or ethylsuccinate)/5ml | |
erythromycin | Oral liquid | 200-250 mg (as stearate or ethylsuccinate)/5ml | |
erythromycin | Tablet | 500 mg (as stearate or ethylsuccinate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amikacin | Injection | 250 mg (as sulfate)/mL in 2-mL vial | |
amikacin | Injection | 50 mg (as sulfate)/mL in 2-mL vial | |
gentamicin | Injection | 10 mg (sulfate)/mL in 2-mL vial | |
gentamicin | Injection | 40 mg (sulfate)/ml in 2-mL vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 10-mL ampoule | |
sulfamethoxazole + trimethoprim | Oral liquid | 200 mg + 40 mg/5 mL | |
sulfamethoxazole + trimethoprim | Tablet | 400 mg + 80 mg | |
sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ciprofloxacin | Injection | 2mg (lactate)/ml | |
ciprofloxacin | Tablet | 500mg (as chlorohydrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
doxycycline | Tablet | 100mg (chlorohydrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chloramphenicol | Capsule | 250 mg | |
chloramphenicol | Capsule | 500 mg | |
chloramphenicol | Oral liquid | 250 mg (palmitate)/5 mL | |
chloramphenicol | Powder for injection | 1 g (sodium succinate) in vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
furazolidone | Oral liquid | 50mg/ml | |
furazolidone | Tablet | 100mg | |
metronidazole | Injection | 5 mg/mL | |
metronidazole | Oral liquid | 250 mg (benzoate)/5 mL | |
metronidazole | Tablet | 500 mg | |
nitrofurantoin | Oral liquid | 25 mg/5 ml | |
nitrofurantoin | Tablet | 100 mg | |
vancomycin | Injection | 500 mg (chlorohydrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clofazimine | Capsule | 100 mg | |
clofazimine | Capsule | 50 mg | |
dapsone | Tablet | 100 mg | |
dapsone | Tablet | 50 mg | |
rifampicin | Solid oral dosage form | 150 mg | |
rifampicin | Solid oral dosage form | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amikacin | Injection | 250 mg (as sulfate)/mL in 4 mL vial | |
capreomycin | Injection | 1g | |
ciprofloxacin | Tablet | 500mg (as chlorohydrate) | |
cycloserine | Solid oral dosage form | 250 mg | |
ethambutol | Tablet | 400mg (chlorohydrate) | |
ethionamide | Tablet | 250 mg | |
isoniazid | Tablet | 100mg | |
kanamycin | Powder for injection | 1 g (as sulfate) in vial | |
ofloxacin | Tablet | 200 mg | |
p-aminosalicylate sodium (PAS sodium) | Granules | 800mg/g (equiv. 579.7 mg/g aminosalicylic acid) | |
pyrazinamide | Tablet | 500 mg | |
rifampicin | Oral liquid | 100mg/5ml | |
rifampicin | Solid oral dosage form | 300 mg | |
streptomycin | Injection | 1g (sulfate) | |
streptomycin | Injection | 5 g (sulfate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amphotericin B | Powder for injection | 50 mg in vial | |
clotrimazole | Vaginal tablet | 500 mg | |
fluconazole | Injection | 2 mg/mL in vial | |
fluconazole | Tablet | 150 mg | |
griseofulvin | Solid oral dosage form | 250 mg | |
itraconazole | Tablet | 100 mg | |
nystatin | Oral liquid | 100 000 IU/ml | |
nystatin | Tablet | 500 000 IU |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
abacavir (ABC) | Tablet | 300 mg | |
didanosine (ddI) | Powder for oral liquid | 10mg/ml 2g | |
didanosine (ddI) | Solid oral dosage form | 100mg | |
didanosine (ddI) | Solid oral dosage form | 400mg | |
lamivudine (3TC) | Oral liquid | 50 mg/5 ml | |
lamivudine (3TC) | Tablet | 150 mg | |
stavudine (d4T) | Capsule | 30 mg | |
stavudine (d4T) | Powder for oral liquid | 5 mg/5 ml | |
zidovudine (ZDV or AZT) | Oral liquid | 50 mg/5 mL | |
zidovudine (ZDV or AZT) | Tablet | 100 mg | |
zidovudine (ZDV or AZT) | Tablet | 300 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
efavirenz (EFV or EFZ) | Capsule | 200 mg | |
efavirenz (EFV or EFZ) | Tablet | 600 mg | |
nevirapine (NVP) | Oral liquid | 50 mg/5 ml | |
nevirapine (NVP) | Tablet | 200 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
indinavir (IDV) | Solid oral dosage form | 400 mg (as sulfate) | |
lamivudine + nevirapine + stavudine | Tablet | 150 mg + 200 mg + 30 mg | |
lamivudine + nevirapine + zidovudine | Tablet | 150 mg + 200 mg + 300 mg | |
lamivudine + zidovudine | Tablet | 150 mg + 300 mg | |
lopinavir + ritonavir (LPV/r) | Oral liquid | 80 + 20 mg/ml | |
lopinavir + ritonavir (LPV/r) | Tablet (heat stable) | 200 mg + 50 mg | |
nelfinavir | Oral liquid | 50mg (mesylate)/g | |
nelfinavir | Tablet | 250mg (as mesylate) | |
ritonavir | Tablet (heat stable) | 100 mg | |
saquinavir (SQV) | Solid oral dosage form | 200 mg (as mesilate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ganciclovir | Injection | 500 mg (sodium) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
diloxanide | Tablet | 500 mg (furoate) | |
metronidazole | Oral liquid | 250 mg (benzoate)/5 mL | |
metronidazole | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amphotericin B | Powder for injection | 50 mg in vial | |
meglumine antimoniate | Solution for IV infusion injection | 85 mg/ml in ampoule | |
pentamidine | Injection | 200 mg | |
sodium stibogluconate | Injection | 100 mg/ml, 1 vial = 30 ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
artemether | Oily injection | 80 mg/ml in 1-ml ampoule | |
artesunate | Suppository | 100mg | |
artesunate | Tablet | 250mg | |
artesunate | Tablet | 50 mg | |
chloroquine | Tablet | 150mg (phosphate) | |
doxycycline | Tablet | 100mg (chlorohydrate) | |
mefloquine | Tablet | 250 mg (hydrochloride) | |
primaquine | Tablet | 15 mg (phosphate) | |
primaquine | Tablet | 5 mg (phosphate) | |
primaquine | Tablet | 7.5 mg (phosphate) | |
quinine | Injection | 300 mg quinine hydrochloride/mL in 2-mL ampoule | |
quinine | Tablet | 300 mg (quinine sulfate) | |
sulfadoxine + pyrimethamine | Tablet | 500 mg + 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
pyrimethamine | Tablet | 25 mg | |
sulfamethoxazole + trimethoprim | Injection | 80 mg + 16 mg/mL in 5-mL ampoule | |
sulfamethoxazole + trimethoprim | Tablet | 800 mg + 160 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
benznidazole | Tablet | 100 mg | |
nifurtimox | Tablet | 120 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 500 mg | |
ibuprofen | Tablet | 200 mg | |
ibuprofen | Tablet | 400 mg | |
paracetamol | Oral liquid | 120 mg/5 mL | |
paracetamol | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amitriptyline | Tablet | 25 mg (hydrochloride) | |
propranolol | Tablet | 10mg (hydrochloride) | |
propranolol | Tablet | 40 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
azithromycin | Powder for oral suspension | 200 mg | |
cyclosporine | Capsule (softgel) | 25mg | |
cyclosporine | Capsule (softgel) | 50mg | |
cyclosporine | Injection | 50mg/ml | |
cyclosporine | Oral liquid | 100 mg/ml | |
mycophenolate mofetil | Tablet | 250 mg | |
mycophenolate mofetil | Tablet | 500 mg | |
tacrolimus | Capsule | 1 mg | |
tacrolimus | Injection | 5 mg/mL | |
tacrolimus | Tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
asparaginase | Powder for injection | 10 000 IU in vial | |
bleomycin | Powder for injection | 15 mg (as sulfate) in vial | |
calcium folinate | Injection | equiv 50 mg folinic acid | |
calcium folinate | Tablet | 15 mg | |
capecitabine | Tablet | 500 mg | |
carboplatin | Injection | 150 mg | |
carboplatin | Injection | 450 mg | |
carmustine | Injection | 100 mg | |
chlorambucil | Tablet | 2 mg | |
cisplatin | Powder for injection | 10 mg in vial | |
cisplatin | Powder for injection | 50 mg in vial | |
citarabine | Injection | 100 mg | |
citarabine | Injection | 500 mg | |
cyclophosphamide | Injection | 1 g | |
cyclophosphamide | Injection | 200 mg | |
cyclophosphamide | Tablet | 50 mg | |
dacarbazine | Injection | 200 mg | |
dacarbazine | Powder for injection | 100 mg in vial | |
dactinomycin | Powder for injection | 500 mcg in vial | |
daunorubicin | Injection | 20mg (chlorohydrate) | |
dexrazoxane | Injection | 500mg (chlorohydrate) | |
docetaxel | Injection | 20 mg/ml | |
docetaxel | Injection | 80mg | |
doxorubicin | Powder for injection | 10 mg (hydrochloride) in vial | |
doxorubicin | Powder for injection | 50 mg (hydrochloride) in vial | |
epirubicin | Injection | 10mg (chlorohydrate) | |
epirubicin | Injection | 50mg (chlorohydrate) | |
etoposide | Injection | 20 mg/mL in 5-mL ampoule | |
etoposide | Tablet | 50 mg | |
filgrastim | Injection | 30,000,000 IU | |
filgrastim | Injection | 48,000,000 IU | |
fludarabine | Injection | 50 mg (phosphate) | |
fluorouracil | Injection | 50 mg/ml in 10-ml ampoule | |
fluorouracil | Injection | 50 mg/ml in 5-ml ampoule | |
gemcitabine | Injection | 1g (chlorohydrate) | |
gemcitabine | Injection | 200mg (chlorohydrate) | |
hydroxycarbamide | Solid oral dosage form | 500 mg | |
ifosfamide | Powder for injection | 1 g in vial | |
imatinib | Tablet | 100 mg (as mesylate) | |
imatinib | Tablet | 400 mg (as mesylate) | |
melphalan | Tablet | 2 mg | |
mercaptopurine | Tablet | 50 mg | |
mesna | Injection | 100 mg/ml in 4-ml ampoules | |
mesna | Tablet | 600 mg | |
methotrexate | Injection | 500mg (sodium) | |
methotrexate | Injection | 50mg (sodium) | |
methotrexate | Injection | 50mg (sodium) + preservant | |
methotrexate | Tablet | 2.5 mg (as sodium salt) | |
mitomycin | Injection | 2 mg | |
mitoxantrone | Injection | 20 mg (dichlorohydrate) | |
oxaliplatin | Injection | 100 mg | |
oxaliplatin | Injection | 50 mg | |
paclitaxel | Injection | 100mg | |
paclitaxel | Injection | 300 mg | |
paclitaxel | Injection | 30mg | |
procarbazine | Capsule | 50 mg (as hydrochloride) | |
rituximab | Injection | 10 mg/mL in 10-mL vial | |
rituximab | Injection | 10 mg/mL in 50-mL vial | |
temozolomide | Tablet | 250mg | |
thalidomide | Tablet | 100 mg | |
thioguanine | Solid oral dosage form | 40 mg | |
tretinoin | Tablet | 10mg | |
vinblastine | Powder for injection | 10 mg (sulfate) in vial | |
vincristine | Powder for injection | 1 mg (sulfate) in vial | |
vinorelbine | Injection | 50 mg (tartrate or ditartrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anastrozole | Tablet | 1mg | |
bicalutamide | Tablet | 150 mg | |
bicalutamide | Tablet | 50 mg | |
ciproterone | Tablet | 250 mg (acetate) | |
dexamethasone | Injection | 4 mg/mL in 1-mL ampoule (as disodium phosphate salt) | |
dexamethasone | Solid oral dosage form | 4 mg | |
diethylstilbestrol | Tablet | 1 mg | |
flutamide | Tablet | 250 mg | |
leuprorelin | Injection | 7.5mg (acetate) | |
medroxyprogesterone acetate | Injection | 500 mg | |
medroxyprogesterone acetate | Tablet | 50 mg | |
prednisone | Tablet | 20 mg | |
prednisone | Tablet | 5 mg | |
prednisone | Tablet | 50 mg | |
tamoxifen | Tablet | 20 mg (as citrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
interferon alpha 2B | Injection | 3 000 000 IU with 1 mL diluent |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
biperiden | Injection | 5 mg (lactate) in 1-ml ampoule | |
biperiden | Tablet | 2 mg (hydrochloride) | |
levodopa + carbidopa | Tablet | 100 mg + 10 mg | |
levodopa + carbidopa | Tablet | 250 mg + 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cyanocobalamin | Injection | 0.1 mg/ ml | |
epoetin alpha | Injection | 2000 IU/ml in 1ml vial | |
epoetin alpha | Injection | 4000 IU/ml in 1ml vial | |
ferrous salt + folic acid | Tablet | equivalent to 60 mg iron + 400 micrograms folic acid | |
folic acid | Tablet | 0.5mg | |
folic acid | Tablet | 1 mg | |
iron | Injection | 20 mg (sacarate)/ml | |
iron | Oral liquid | 15 mg (sulfate)/5ml | |
iron | Oral liquid | 25 mg (sulfate)/ml | |
iron | Tablet | 60 mg (sulfate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dalteparin | Injection | 25,000 IU (sodium)/ml | |
enoxaparin | Injection | 100mg/ml in 0.4ml vial | |
enoxaparin | Injection | 100mg/ml in 0.6ml vial | |
heparin sodium | Injection | 5000 IU/mL in 5-mL vial | |
phytomenadione | Injection | 10 mg/mL in 1-mL vial | |
protamine sulfate | Injection | 10 mg/mL in 5-mL ampoule | |
tranexamic acid | Injection | 1g | |
tranexamic acid | Tablet | 250mg | |
warfarin | Tablet | 2.5 mg (sodium) | |
warfarin | Tablet | 5 mg (sodium salt) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
polygeline | Injection | 3.5% in 500ml vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
factor VIII concentrate | Injection | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atenolol | Tablet | 100 mg | |
atenolol | Tablet | 50 mg | |
diltiazem | Tablet | 60 mg (chlorohydrate) | |
glyceryl trinitrate | Injection | 5 mg/mL | |
isosorbide dinitrate | Tablet | 10 mg | |
isosorbide dinitrate | Tablet (sublingual) | 5 mg | |
isosorbide mononitrate | Tablet | 20mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
adenosine | Injection | 3 mg/mL in 2-mL ampoule | |
amiodarone | Injection | 50 mg/mL in 3-mL ampoule (hydrochloride) | |
amiodarone | Tablet (HCI) | 200 mg (hydrochloride) | |
atenolol | Tablet | 100 mg | |
atenolol | Tablet | 50 mg | |
digoxin | Tablet | 250 mcg | |
lidocaine | Injection | 2% (without preservant) | |
propafenone | Tablet | 150 mg | |
verapamil | Injection | 2.5 mg (hydrochloride)/mL in 2-mL ampoule | |
verapamil | Tablet | 80 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amlodipine | Tablet | 10 mg (besylate) | |
amlodipine | Tablet | 5 mg (besylate) | |
atenolol | Tablet | 100 mg | |
atenolol | Tablet | 50 mg | |
captopril | Tablet | 25 mg | |
enalapril | Tablet | 10 mg (maleate) | |
enalapril | Tablet | 20 mg (maleate) | |
hydrochlorothiazide | Solid oral dosage form | 25 mg | |
losartan | Tablet | 50mg (potassium) | |
methyldopa | Tablet | 250 mg | |
nifedipine | Tablet (prolonged release) | 30mg | |
sodium nitroprusside | Powder for infusion | 50 mg in ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bisoprolol | Tablet | 5mg (fumarate) | |
carvedilol | Tablet | 25 mg | |
carvedilol | Tablet | 6.25 mg | |
digoxin | Oral liquid | 50 micrograms/mL | |
digoxin | Tablet | 250 mcg | |
dobutamine | Injection | 12.5mg (hydrochloride)/mL in 20 ml vial | |
dopamine | Injection | 40 mg/mL (hydrochloride) in 5-mL vial | |
epinephrine (adrenaline) | Injection | 1 mg (as hydrochloride or hydrogen tartrate) in 1-ml ampoule | |
furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Solid oral dosage form | 25 mg | |
lanatoside C | Injection | 200mcg/ml | |
norepinephrine | Injection | 1 mg/mL in 4-mL vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetylsalicylic acid | Tablet | 80 to 100 mg | |
alteplase | Injection | 50mg | |
streptokinase | Powder for injection | 1.5 million IU in vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atorvastatine | Tablet | 20 mg (calcium salt) | |
atorvastatine | Tablet | 40 mg (calcium salt) | |
gemfibrozil | Tablet | 600mg | |
simvastatin | Tablet | 20 mg | |
simvastatin | Tablet | 40 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
indomethacin | Injection | 1 mg (sodium salt) | |
nimodipine | Capsule | 30 mg | |
nimodipine | Injection | 0.2 mg/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clotrimazole | Cream | 1% | |
clotrimazole | Solution | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
fusidic acid | Cream | 2% | |
mupirocin | Ointment | 2% | |
nitrofural | Cream | 0.2% (35g) | |
nitrofural | Cream | 0.2% (500g) | |
silver sulfadiazine | Cream | 1% (400-500g) | |
silver sulfadiazine | Cream | 1% (50g) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clobetasol | Cream | 0.05% | |
hydrocortisone | Cream | 1% (acetate) | |
triamcinolone | Lotion | 0.025% (acetonide) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
benzoyl peroxide | Gel | 4-5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
benzyl benzoate | Lotion | 25% | |
permethrin | Cream | 5% | |
permethrin | Lotion | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acitretin | Tablet | 25mg | |
isotretinoin | Tablet | 20mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
cyclopentolate | Solution (eye drops) | 1% (hydrochloride) | |
fluorescein | Injection | 10% | |
phenylephrine | Solution (eye drops) | 2.5% (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
barium sulfate | Oral liquid | N/A | |
barium sulfate | Powder for enema | according to availability | |
dimeglumine gadopentate | Injection | 469 mg/ml | |
iodamide meglumine | Injection | 65% in 40ml vial | |
iohexol | Injection | equiv 300mg iodo/ml in 50 or 100ml vial | |
iohexol | Injection | equiv 350mg iodo/ml in 50 or 100ml vial | |
iopamidol (iopromide) | Injection | equiv 300 mg iodine/mL in 50 or 100 ml vial | |
iopamidol (iopromide) | Injection | equiv 370 mg iodine/mL in 50 or 100 mL vial | |
meglumine iothalamate | Injection | 60% in 50ml vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bisacodyl | Suppository | 10 mg | |
bisacodyl | Tablet | 5 mg | |
macrogol 3350 | Powder | with potassium and sodium chloride, sodium bicarbonate, and with or without sodium sulfate | |
monobasic sodium phosphate + dibasic sodium phosphate | Rectal solution | 16g + 6g/100ml | |
simethicone | Oral liquid | 80 mg/ml or more (drops) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorhexidine | Solution | 7.1% (digluconate) delivering 4% chlorhexidine (for umbilical cord care) | |
ethyl alcohol (ethanol) | Solution | 70% | |
hydrogen peroxide | Solution | 3% | |
iodine-povidone | Topical forms | 7-10% (foam and solution) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glutaral | Solution | 2% | |
sodium hypochlorite | Solution | 10% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
furosemide | Injection | 10 mg/mL in 2-mL ampoule | |
furosemide | Tablet | 40 mg | |
hydrochlorothiazide | Solid oral dosage form | 12.5 mg | |
hydrochlorothiazide | Solid oral dosage form | 25 mg | |
mannitol | Injectable solution | 20% | |
spironolactone | Tablet | 100mg | |
spironolactone | Tablet | 25 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aluminum + magnesium hydroxide | Oral liquid | 400mg + 400mg/5ml | |
bismuth subsalicylate | Oral liquid | 87.33mg/5ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
pancrea | Injection | 40 mg (sodium salt) | |
pancrea | Solid oral dosage form | 20 mg | |
ranitidine | Injection | 25 mg/mL (as hydrochloride) in 2-mL ampoule | |
ranitidine | Tablet | 150 mg (as hydrochloride) | |
ranitidine | Tablet | 300mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dimenhydrinate | Injection | 10mg/mL in 5-mL vial | |
dimenhydrinate | Tablet | 50 mg | |
metoclopramide | Injection | 5 mg (hydrochloride)/mL in 2-mL ampoule | |
metoclopramide | Tablet | 10 mg (hydrochloride) | |
ondansetron | Injection | 2 mg (chlorohydrate)/ml in 4-mL vial | |
ondansetron | Tablet | 8 mg (chlorohydrate) | |
promethazine | Injection | 25mg (hydrochloride)/ml |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
sulfasalazine | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Injection | 250 mcg/mL | |
atropine | Injection | 500 mcg (sulfate)/mL | |
hyoscine hydrobromide | Injection | 20 mg/mL | |
hyoscine hydrobromide | Tablet | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
oral rehydration salts | Powder | 20.5g/L |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
zinc sulfate | Oral liquid | 10mg | |
zinc sulfate | Solid oral dosage form | 20 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
monoethanolamine | Injection | 5% (oleate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
betamethasone | Injection | 4 mg (sodium phosphate)/mL | |
dexamethasone | Injection | 2 mg (phosphate, as sodium salt)/mL in 2-mL vial | |
dexamethasone | Oral liquid | 2 mg (phosphate, as sodium salt)/5 mL | |
dexamethasone | Solid oral dosage form | 0.5 mg | |
dexamethasone | Solid oral dosage form | 4 mg | |
hydrocortisone | Powder for injection | 100 mg (as sodium succinate) in vial | |
methylprednisolone | Injection | 100 mg (sodium succinate) | |
methylprednisolone | Injection | 500 mg (sodium succinate) | |
prednisone | Oral liquid | 5 mg/5 mL | |
prednisone | Tablet | 20 mg | |
prednisone | Tablet | 5 mg | |
prednisone | Tablet | 50 mg | |
triamcinolone | Injection | 10 mg/mL in 5-mL vial | |
triamcinolone | Injection | 40 mg (acetonide)/mL in 1-mL vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chorionic gonadotropin (human) | Injection | 5000 IU/mL | |
danazol | Tablet | 200 mg | |
leuprorelin | Injection | 3.75mg | |
menotropin | Injection | 75 IU |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
alendronic acid | Tablet | 70mg (as alendronate sodium) | |
pamidronate disodium | Injection | 90 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
testosterone | Injection | 250 mg (enanthate)/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ethinylestradiol + levonorgestrel | Tablet | 30 mcg + 150 mcg | |
levonorgestrel | Tablet | 1.5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
medroxyprogesterone acetate | Depot injection | 150 mg/mL in 1-mL vial |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
conjugated estrogens | Tablet | 0.625 mg | |
conjugated estrogens + medroxyprogesterone | Tablet | 0.625mg + 2.5mg (acetate) | |
estradiol | Tablet | 1 mg | |
estriol | Vaginal cream | 0.1% | |
medroxyprogesterone acetate | Tablet | 5 mg | |
norethisterone enantate | Oily solution | 200 mg/ml in 1-ml ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glibenclamide | Tablet | 5 mg | |
intermediate-acting insulin | Injection | 100 IU/ml in 10-ml vial | |
metformin | Tablet | 500 mg (hydrochloride) | |
metformin | Tablet | 850 mg (hydrochloride) | |
NPH insulin (intermediate-acting insulin) | Injection | 100 IU/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clomifene | Tablet | 50 mg (citrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
medroxyprogesterone acetate | Tablet | 5 mg | |
progesterone | Tablet | 100 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
levothyroxine | Tablet | 100 mcg (sodium salt) | |
levothyroxine | Tablet | 50 mcg (sodium salt) | |
methimazole | Tablet | 20 mg | |
methimazole | Tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
bromocryptin | Tablet | 2.5mg | |
cabergoline | Tablet | 500 mcg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
tuberculin, purified protein derivative (PPD) | Injection | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
anti rabies human serum | Injection | according to availability | |
anti-D immunoglobulin (human) | Injection | N/A | |
anti-hepatitis B immunoglobulin | Injection | 200 UI/ ml | |
antibothropic serum | Injection | N/A | |
anticrothalic serum | Injection | N/A | |
antilachesic serum | Injection | N/A | |
antiloxoscelic serum | Injection | N/A | |
antitetanus immunoglobulin (human) | Injection | 250 UI | |
diphtheria antitoxin | Injection | N/A | |
tetanus antitoxin | Injection | according to availability |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
BCG vaccine | Injection | N/A | |
diphtheria vaccine | Injection | adult | |
diphtheria vaccine | Injection | pediatric | |
haemophilus influenzae type b vaccine (Hib vaccine) | N/A | N/A | |
hepatitis A vaccine | N/A | N/A | |
hepatitis B vaccine | Injection | adult | |
hepatitis B vaccine | Injection | pediatric | |
HSUR influenza vaccine | Injection | adult | |
HSUR influenza vaccine | Injection | pediatric | |
measles vaccine | Injection | N/A | |
meningococcal meningitis vaccine | N/A | N/A | |
mumps vaccine | N/A | N/A | |
pertussis vaccine | N/A | N/A | |
pneumococcal vaccine | Injection | adult | |
pneumococcal vaccine | Injection | pediatric | |
poliomyelitis vaccine | Injection | N/A | |
poliomyelitis vaccine | Oral liquid | N/A | |
rabies vaccine | Injection | inactivated | |
rabies vaccine | Injection | prepared in infant mouse brain | |
rotavirus vaccine | N/A | N/A | |
rubella vaccine | N/A | N/A | |
tetanus vaccine | Injection | N/A | |
varicella vaccine | N/A | N/A | |
yellow fever vaccine | N/A | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atracurium | Injection | 10 mg/mL (besylate) | |
neostigmine | Injection | 500 mcg (methylsulfate) in 1-mL ampoule | |
neostigmine | Tablet | 15 mg (bromide) | |
pyridostigmine | Injection | 1 mg (bromide)/mL | |
pyridostigmine | Tablet | 60 mg (bromide) | |
rocuronium bromide | Injection | 10mg/ml | |
suxamethonium | Injection | 500mg | |
vecuronium | Injection | 4 mg (bromide)/mL in ampoule |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
baclofen | Tablet | 10 mg | |
orfenadrine | Injection | 30mg (citrate)/ml in 2ml vial | |
orfenadrine | Tablet | 100mg (citrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aciclovir | Ointment | 3% W/W | |
ciprofloxacin | Solution (eye drops) | 0.3% | |
sulfacetamide | Solution (eye drops) | 10-15% (sodium) | |
tetracycline | Eye ointment | 1% (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
diclofenac | Solution (eye drops) | 0.1% | |
prednisolone | Solution (eye drops) | 1% (acetate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
proxymetacaine | Solution (eye drops) | 0.5% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
acetazolamide | Tablet | 250 mg | |
latanoprost | Solution (eye drops) | 0.005% | |
pilocarpine | Solution (eye drops) | 2% (hydrochloride or nitrate) | |
timolol | Solution (eye drops) | 0.5% (maleate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
atropine | Solution (eye drops) | 1% (sulfate) | |
tropicamide | Solution (eye drops) | 1% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ketotifen | Solution (eye drops) | 0.025% | |
nafazoline | Solution (eye drops) | 0.0125% (chlorohydrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
artificial tears | Gel | 0.3% (eye) | |
artificial tears | Solution (eye drops) | 0.3% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ergometrine | Injection | 0.2 mg/mL (maleate) in 1-mL ampoule | |
misoprostol | Vaginal tablet | 25 mcg | |
oxytocin | Injection | 10 IU in 1-mL ampoule | |
oxytocin | Injection | 5 IU/mL |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
isoxsuprine | Injection | 5mg (chlorohydrate)/ml in 2ml vial | |
isoxsuprine | Tablet | 10mg (chlorohydrate) | |
nifedipine | Immediate-release capsule | 10 mg | |
salbutamol | Tablet | 4 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
hemodialysis solution | Solution for IV infusion | N/A | |
hemodialysis solution | Solution for IV infusion | with 35-30 mEq/L bicarbonate | |
intraperitoneal dialysis solution (of appropriate composition) | Solution for IV infusion | 1.5% glucose | |
intraperitoneal dialysis solution (of appropriate composition) | Solution for IV infusion | 2.5% glucose | |
intraperitoneal dialysis solution (of appropriate composition) | Solution for IV infusion | 4.25% glucose |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
chlorpromazine | Injection | 25 mg (hydrochloride)/mL in 2-mL ampoule | |
chlorpromazine | Tablet (scored) | 100 mg | |
clozapine | Tablet | 100mg | |
clozapine | Tablet | 25mg | |
fluphenazine | Injection | 25 mg (decanoate or enantate) in 1-mL ampoule | |
haloperidol | Injection | 5 mg/mL in 1-mL ampoule | |
haloperidol | Injection | 50 mg (as decanoate)/mL | |
haloperidol | Oral liquid | 2 mg/mL | |
haloperidol | Tablet | 10 mg | |
periciazine | Oral liquid | 40mg/ml (1mg/drop) | |
risperidone | Tablet | 2mg | |
sulpyride | Tablet | 200mg | |
thioridazine | Tablet | 100 mg (chlorohydrate) | |
trifluoperazine | Tablet | 5 mg (chlorohydrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
amitriptyline | Tablet | 25 mg | |
fluoxetine | Solid oral dosage form | 20 mg (as hydrochloride) | |
mirtazapine | Tablet | 30mg | |
sertraline | Tablet | 50 mg (chlorohydrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
carbamazepine | Tablet (scored) | 200 mg | |
lithium carbonate | Solid oral dosage form | 300 mg | |
valproic acid (sodium valproate) | Tablet (enteric-coated) | 500 mg (sodium valproate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
alprazolam | Tablet | 500 mcg | |
clonazepam | Tablet | 2mg | |
diazepam | Injection | 5 mg/mL | |
diazepam | Tablet (scored) | 10 mg | |
levomepromazine | Tablet | 100 mg (maleate) | |
zolpidem | Tablet | 10mg (tartrate) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
clomipramine | Capsule | 25 mg (hydrochloride) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
disulfiram | Tablet | 500 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
methylphenidate | Tablet | 10 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
aminophylline | Injection | 25 mg/mL | |
beclometasone | Inhalation (aerosol) | 250 micrograms (dipropionate) per dose | |
beclometasone | Metered dose inhaler (aerosol) | 50 micrograms (dipropionate) per dose | |
epinephrine (adrenaline) | Injection | 1 mg (as hydrochloride or hydrogen tartrate) in 1-ml ampoule | |
ipratropium bromide | Inhalation (aerosol) | 20 micrograms/metered dose | |
salbutamol | Metered dose inhaler (aerosol) | 100 mcg (as sulfate) per dose | |
salbutamol | respirator solution for use in nebulizers | 5 mg (as sulfate)/mL | |
salmeterol + fluticasone | Metered dose inhaler (aerosol) | 25 mcg + 250mcg/dose | |
salmeterol + fluticasone | Metered dose inhaler (aerosol) | 25mcg + 125mcg | |
theophylline | Tablet (prolonged release) | 125 mg | |
theophylline | Tablet (prolonged release) | 250 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dextromethorphan | Oral liquid | 15mg (hydrobromide)/5ml | |
surfactant | Injection | N/A |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ofloxacin | ear drops | 0.3% |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
oral rehydration salts | Powder | 20.5g/L |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
glucose | Parenteral formulation | 10% (1000 mL) | |
glucose | Parenteral formulation | 33.3% (20 mL) | |
glucose | Parenteral formulation | 5% (100 mL) | |
glucose | Parenteral formulation | 5% (1000 mL) | |
glucose | Parenteral formulation | 5% (250 mL) | |
glucose | Parenteral formulation | 5% (500 mL) | |
glucose | Parenteral formulation | 50% (1 L) | |
glucose with sodium chloride | Injectable solution | 5% glucose, 0.9% sodium chloride (equivalent to 150 mmol/L Na+ and 150 mmol/L Cl-) | |
polyelectric solution | Parenteral formulation | N/A | |
potassium chloride | Injection | 20% | |
ringer lactate solution | Parenteral formulation | 1000ml | |
sodium bicarbonate | Injection | 8.4% | |
sodium chloride | Parenteral formulation | 0.9% (1 L) | |
sodium chloride | Parenteral formulation | 0.9% (100 mL) | |
sodium chloride | Parenteral formulation | 0.9% (20 mL) | |
sodium chloride | Parenteral formulation | 0.9% (250 mL) | |
sodium chloride | Parenteral formulation | 0.9% (5 mL) | |
sodium chloride | Parenteral formulation | 0.9% (500 mL) | |
sodium chloride | Parenteral formulation | 20% (20 mL) |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
water for injection | Injection | 1L ampoules | |
water for injection | N/A | 10-ml ampoules | |
water for injection | N/A | 2-ml ampoules | |
water for injection | N/A | 5-mL ampoules |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
ascorbic acid | Tablet | 100 mg | |
calcium carbonate | Tablet | 1.25g | |
calcium gluconate | Injection | 10% | |
ergocalciferol | Oral liquid | 250 micrograms/ml (10 000 IU/ml) | |
ergocalciferol | Solid oral dosage form | 1.25 mg (50 000 IU) | |
folic acid | Tablet | 0.5mg | |
hydroxocobalamin | Injection | 1 mg/mL | |
pyridoxine | Tablet | 50mg (chlorohydrate) | |
retinol | Capsule | 100 000 IU (as palmitate) | |
retinol | Capsule | 200 000 IU (as palmitate) | |
retinol | Capsule | 50 000 IU (as palmitate) | |
thiamine | Injection | 100mg (chlorohydrate)/ml | |
thiamine | Tablet | 100mg | |
vitamin D | Injection | 1mcg/ml | |
vitamin D | Tablet | 250mcg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
dimenhydrinate | Injection | 10mg/mL in 5-mL vial | |
dimenhydrinate | Tablet | 50 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
oxybutynin | Tablet | 5 mg |
Medicine | Pharmaceutical form type | Composition | Observation |
---|---|---|---|
finasteride | Tablet | 5mg | |
tamsulosin | Tablet | 400mcg |